Skip to content

ASMact: Study on Management of Bronchial Asthma

Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07412769
Enrollment
500
Registered
2026-02-17
Start date
2025-11-05
Completion date
2026-06-30
Last updated
2026-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Acute, Asthma Childhood, Asthma Crisis, Asthma in Children

Keywords

asthma attack, exacerbation,

Brief summary

Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.

Detailed description

Patients aged 6 to 17 years presenting to the emergency department with an acute asthma exacerbation were included. Clinical outcomes were compared between a pre-intervention period (October 2024-May 2025) and a post-intervention period (October 2025-May 2026). Between the two study periods, a structured educational intervention targeting medical and nursing staff was implemented. The intervention consisted of didactic lectures, clinical simulation sessions, case-based discussions, and the dissemination of updated diagnostic and therapeutic flowcharts based on the 2025 Global Initiative for Asthma (GINA) guidelines.

Interventions

None listed

Sponsors

Meyer Children's Hospital IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Age between 6 and 17 years * Presentation to the emergency department with a diagnosis of acute asthma exacerbation * Evaluation in the emergency department of one of the participating centers during the study periods

Exclusion criteria

* Age \< 6 years or \> 17 years * Diagnosis other than acute asthma exacerbation * Incomplete or missing clinical data * Patients transferred from other hospitals already treated for the same episode * history of allergy to any drugs used in the protocol

Design outcomes

Primary

MeasureTime frameDescription
Change in the number of correctly reported diagnoses before and after interventionPre-intervention and through study completion, an average of 9 monthsAssessment of adherence to guideline-based diagnostic and therapeutic management of pediatric patients presenting with acute asthma exacerbations in the emergency department.
Percentage of patients with correct timing, dosage, and method of drug administration before and after interventionPre-intervention and through study completion, an average of 9 months
Percentage of patients with correct follow-up at dischargePre-intervention and through study completion, an average of 9 months
Percentage of patients in whom additional drugs are used in refractory casesPre-intervention and through study completion, an average of 9 months
Percentage of patients with correct therapy at dischargePre-intervention and through study completion, an average of 9 months

Secondary

MeasureTime frameDescription
Incidence of acute asthma exacerbationsPre-intervention and through study completion, an average of 9 monthsNumber of emergency department visits for acute asthma exacerbations among pediatric patients during the pre- and post-intervention periods.

Countries

Italy

Contacts

CONTACTGrazia Fenu
grazia.fenu@meyer.it+390555662388

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026